Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactobacillus plantarum for preventing acute GvHD in children
NCT03057054Phase 3Active, not recruiting
- Sponsor
- Children's Oncology Group
- Start
- Apr 2018
- Primary completion
- Jun 2022
- Modality
- Live Biotherapeutic Products
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of lactobacillus plantarum in Acute Graft-Versus-Host Disease (aGVHD), sponsored by Children's Oncology Group. Started Apr 2018; status: active, not recruiting.
02
Drugs
lactobacillus plantarum
03
Conditions
Acute Graft-Versus-Host Disease (aGVHD)
Beyond the preview
Go deeper on NCT03057054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057054.